Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-06-26
2007-06-26
O'Hara, Eileen B. (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S314000, C530S327000
Reexamination Certificate
active
10168789
ABSTRACT:
The present invention relates to amino acid sequences for novel tachykinin polypeptides and base sequences encoding them, agonists and antagonists of such polypeptides, pharmaceutical compositions comprising them, and the like.
REFERENCES:
patent: 5137873 (1992-08-01), Yankner
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5876948 (1999-03-01), Yankner
patent: 5891842 (1999-04-01), Kream
patent: 6774219 (2004-08-01), Hostetter et al.
patent: 0532456 (1992-08-01), None
patent: 05-163159 (1993-06-01), None
patent: 10-306099 (1998-11-01), None
patent: WO 86/03495 (1986-06-01), None
patent: WO 92/02248 (1992-02-01), None
patent: WO/9202248 (1992-02-01), None
patent: WO 94/20500 (1994-09-01), None
patent: WO 98/22497 (1998-05-01), None
patent: WO 99/46367 (1999-09-01), None
patent: WO 99/53021 (1999-10-01), None
Francklyn, C., Aminoacyl-tRNA Synthetases: Versatile Players in the Changing Theater of Translation, RNA, vol. 8, pp. 1363-1372 (2002).
Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th Ed., McGraw-Hill, NY, (1996).
T. Kempe, et al. “Multiple-copy Genes: Production and Modification of Monomeric Peptides From Large Multimeric Fusion Proteins” GENE 39:239-45 (1985).
A. Jeng, et al. “A Radioimmunoassay for Measuring α-Amidating Enzyme Activity” Analytical Biochemistry 185:213-19(1990).
G. Bitan, et al. “Synthesis and Biological Activity of Novel Backbone-Bicyclic Substance-P Analogs Containing Lactarn and Disulfide Bridges” Journal of Peptide Research 49:421-26(1997).
Kokyu 7[7] 764772(1988).
Y. Shimohigashi, et al. “Drug Design of Neuropeptides for Hypotensive Therapeutics”Study Report by Asahi-Glass Foundation 59:: 115-24(1991.
A. Dutta, et al. “Analogues of Substance P. Peptides Containing D-Amino Acid Residues in Various Positions of Substance P and Displaying Agonist or Receptor Selective Antagonist Effects” J. Med. Chem 29:1163-71(1986).
S. Nakanishi, et al. “Neuropeptides and Neuroendocrinological Control” Development of Medical Science 146[4]:223-230(1988).
Japanese Clinical 48[5]:98-104(1990).
C.J. Helke, et al. “Diversity in Mammalian Tachykinin Peptidergic Neurons: Multiple Peptides, Receptors, And Regulatory Mechanisms” The FASEB Journal 4:1606-15(1990).
Z. Gao, et al. “Recent Advances in Neurokinin Receptor Antagonists” Current Medicinal Chemistry 6:375-88(1999).
“Tachykinin” Kokyu (ASPRILATION), vol. 7[7], pp. 764-772(1988).
Y. Shimohigashi, et al. “Drug Design of Neuropeptides for Hypotensive Therapeutics” Study Report by Asahi-Glass Foundation, vol. 59, pp. 115-124(1992).
S. Nakanishi, et al. “Nervous Peptide and Neuroendocrine Regulation” Development of Medical Science, vol. 146[4], pp. 223-230(1988).
Japanese Clinical, vol. 48, No. 5, pp. 98-104(1990).
Waugh, D. et al., “Tachykinins with Unusual Structural Features from a Urodele, the Amphiuma, an Elasmobranch, the Hammerhead Shark, and a Agnathan, the River Lamprey”,Peptides, (1995) vol. 16, No. 4, pp. 615-621.
Yue, K. et al., “Characterization of a Desmocollin Isoform (Bovine DSC3) Exclusively Expressed in Lower Layers of Stratified Epithelia”,Journal of Cell Science(1995), vol. 108, pp. 2163-2173.
Legan, P.K. et al., “The Bovine Desmocollin Family: A New Gene and Expression Patterns Reflecting Epithelial Cell Proliferation and Differentiation”,The Journal of Cell Biology, (1994), vol. 126, No. 2, pp. 507-518.
Itoh Yasuaki
Kitada Chieko
Nishi Kazunori
Conlin David G.
Edwards Angell Palmer & & Dodge LLP
O'Hara Eileen B.
Takeda Pharmaceutical Company
LandOfFree
Tachykinin-like polypeptides and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tachykinin-like polypeptides and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tachykinin-like polypeptides and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3861900